New Report Just Published: World Ventricular Assist Devices Market Report

LONDON, UNITED KINGDOM, Jul 07 (MARKET WIRE) --
Reportlinker.com just added a new market research report to its catalogue.

World Ventricular Assist Devices Market

www.reportlinker.com/p0109889/World-Ventricular-Assist-Devices-Market.html?utm_s
urce=MRKW&utm_medium=PR&utm_campaign=MRKW

This report analyzes the worldwide markets for Ventricular Assist Devices
in Millions of US$. The report provides separate comprehensive analytics
for the US, Europe, and Rest of World. Annual forecasts are provided for
the period of 2006 through 2015. A five-year historic analysis is also
provided for these markets with annual market analytics. The report
profiles 28 companies including many key and niche players worldwide such
as Abiomed, Inc., Berlin Heart GmbH, EvaHeart Medical USA, Inc.,
HeartWare Limited, Jarvik Heart, Inc., MEDOS Medizentechnik AG, MicroMed
Cardiovascular, Inc., SynCardia Systems, Inc., Terumo Heart, Inc.,
Thoratec Corporation, Ventracor Limited, and World Heart Corporation.
Market data and analytics are derived from primary and secondary
research. Company profiles are mostly extracted from URL research and
reported select online sources.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3

II. EXECUTIVE SUMMARY

1. Introduction II-1
Global & Regional Market Analysis II-1
Opportunities in VAD Market II-1
Destination Therapy - An Immense Potential Opportunity II-1
Next Generation Devices to Offer Pronounced Scope II-2
Heart Transplantation Scenario II-2
Table 1: Number of Heart Transplants Worldwide (2000-2006)
(In Units) (includes corresponding Graph/Chart) II-2

Table 2: Heart Transplants Worldwide (2008E): Percentage
Share Breakdown by Country/Region (includes corresponding
Graph/Chart) II-3

2. Competition II-4
Thoratec is the Clear Leader II-4
Leading Players in the Global VAD Market II-4
Table 3: Leading Players in the Global VAD and Circulatory
Support Market (2007): Percentage Breakdown of Value Sales
for Thoratec, Abiomed, WorldHeart and Others (includes
corresponding Graph/Chart) II-4

Table 4: Global VAD Market (2007): Implantations in Units by
Select Player - Thoratec, MicroMed Cardiovascular, Berlin
Heart, Ventracor, Terumo Heart and HeartWare (includes
corresponding Graph/Chart) II-4
Competition Heats Up II-5
Competitive Technologies II-5

3. VAD - An Insight II-6
Heart - The Vital Organ II-6
Heart Diseases II-6
Congenital Heart Disease II-6
Congestive Heart Failure II-6
Mechanical Circulatory Support Systems II-6
Total Artificial Heart II-6
VADs II-7
VADs Usage by Indication and Time Duration II-7
Types II-8
VAD Components II-8
VAD Pumps II-8
Li-Ion Batteries: Reliable Power Sources for Portable
Medical Devices II-9
Implantation Procedure II-9
Aftercare II-9
Complications II-10
Infection II-10
Internal Bleeding II-10
Thrombus II-10
Table 5: Percentage Breakdown of Possible Complications in
VADs Usage by Type - Infection, Bleeding, Arrhythmia,
Renal Dysfunction, Respiratory Dysfunction, Neurologic
Dysfunction, RV Dysfunction and Others (includes
corresponding Graph/Chart) II-10
Pricing of VAD II-11
Table 6: Average Selling Prices of Select VADs by Company
and Model II-11
VAD Improvisations II-11
LVADs - An Introduction II-12
LVAD Milestones II-12
An Effective Therapeutic Device for End-Stage Congestive
Heart Failure II-13
Ventricular Assistance Vs. Heart Replacement II-13

4. An Insight into the First, Second and Third Generation VADs II-15
First Generation VAD II-15
Second Generation VAD II-15
Rotary Axial Flow Pumps II-15
Drawbacks of Axial Flow Pump II-16
Third Generation VAD II-16
Select First, Second and Third Generation Implantable VADs II-17

5. Reimbursement Scenario II-18
Government Regulations II-18
The US II-18
Canada II-18
Europe II-18

6. Product Approvals/Innovations/Introductions II-19
Thoratec Receives FDA Approval for its HeartMate II LVAS II-19
HeartWare Receives Conditional Approval for its HeartWare LVAS II-19
Abiomed Receives CE Mark for AB5000 Portable Driver II-19
Ventracor Receives USFDA Approval to Use its VentrAssist
Device in Clinical Trials II-19
NewCorTec Launches a New LVAD II-20
WorldHeart Launches New Pediatric VAD II-20
Ventracor Obtains FDA Approval for VentrAssist's US BTT Trial II-20
MicroMed Cardiovascular Obtains 5-Year CE Mark Extension for
DeBakey II-20
Thoratec Submits PMA for HeartMate II Left Ventricular Assist
System II-20
Ventracor Receives 'Commercial Ready' Grant to Develop
VentrAssist LVAD II-20
Terumo Heart Obtains CE Mark for its DuraHeart(R) LVAS in Europe II-21
Abiomed Acquires Regulatory Approval in Australia for Impella
LP 2.5 LVAD II-21
Abiomed Receives FDA Approval for Impella 2.5 VAD Pilot Trials II-21
Biophan Develops New MYO-VAD II-21
Queensland University of Technology Invents Counter-Flow Pump II-22
HeartWare Obtains German Regulatory Approval for its HVAD(TM) II-22
Abiomed Receives Regulatory Approval in France for its AB5000 VAD II-22
MiTi Develops MitiHeart LVAD for Heart Failure Patients II-22
MicroMed Cardiovascular's 'DeBakey VAD Child' Receives FDA
Approval II-23

7. Recent Industry Activity II-24
UPMC Wins Gold Seal of Approval(TM) to Use VADs in Destination
Therapy II-24
E-Wilson Acquires 97% of the MicroMed Cardiovascular's
Outstanding Shares II-24
World Heart Enters into Partnership with Abiomed II-24
Thoratec Corporation Enters into Agreement with Levitronix II-25
World Heart Implants First Rotary VAD II-25
Abiomed Unveils a New Educational as well as Service Program II-25
MicroMed Technology Merges with Salmon Express II-26
Abiomed Acquires Impella CardioSystems II-26
Thoratec Announces 40% Increase in Medicare Refund on VADs
Used in DT II-26
National Heart, Lung and Blood Institute Awards Contract worth
$6.95 Million II-26

8. Focus on Select Global Players II-28
Abiomed, Inc. (USA) II-28
Berlin Heart GmbH (Germany) II-28
EvaHeart Medical USA, Inc. (USA) II-28
HeartWare Limited (Australia) II-28
Jarvik Heart, Inc. (USA) II-28
MEDOS Medizentechnik AG (Germany) II-29
MicroMed Cardiovascular, Inc. (USA) II-29
SynCardia Systems, Inc. (USA) II-29
Terumo Heart, Inc. (USA) II-29
Thoratec Corporation (USA) II-29
Ventracor Limited (Australia) II-30
World Heart Corporation (USA) II-30

9. Global Market Perspective II-31
Table 7: World Recent Past, Current & Future Market Analysis
for Ventricular Assist Devices by Geographic Region - US,
Europe, and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2006 through
2015 (includes corresponding Graph/Chart) II-31

Table 8: World Historic Review for Ventricular Assist Devices
by Geographic Region - US, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2001 through 2005 (includes corresponding
Graph/Chart) II-31

Table 9: World 10-Year Perspective for Ventricular Assist
Devices by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Europe, and Rest of World Markets for Years
2006, 2009 & 2015 (includes corresponding Graph/Chart) II-32

III. MARKET

1. The United States III-1
A.Market Analysis III-1
Heart Ailments - The Death Sentence III-1
Table 10: Incidence, Prevalence and Deaths due to Heart
Ailments in the US (2007) (includes corresponding
Graph/Chart) III-1
Huge Waiting Time for Heart Transplant III-1
VADs for Heart Failures III-2
Table 11: VAD Market in the US: Percentage Breakdown by
Indication: Bridge-to-Transplant, Destination Therapy,
Bridge-to-Recovery and Others (includes corresponding
Graph/Chart) III-2
Market Dynamics III-2
High Selling Price III-2
Drug Industry Poses Intense Competition III-2
Lack of Timely and Quick FDA Approvals III-3
Reimbursement III-3
CMS Increases LVAD Coverage for Heart Patients III-3
New Facility Criteria to Hospitals on VAD Implantation for
Destination Therapy III-4
Competition III-4
Table 12: Leading Players in the US Bridge-to-Transplant
VAD Market (2008E) - Percentage Breakdown of Sales for
Thoratec and Others III-4

Table 13: Leading Players in the US destination therapy
VAD Market (2007): Percentage Breakdown of Sales for
Thoratec and Others III-5
Product Approvals/Innovations/Introductions III-5
Strategic Corporate Developments III-7
Key Players III-10
B.Market Analytics III-12
Table 14: US Recent Past, Current & Future Analysis for
Ventricular Assist Devices Market Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2015 (includes corresponding Graph/Chart) III-12

Table 15: US Historic Review for Ventricular Assist Devices
Market Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2001 through 2005 (includes
corresponding Graph/Chart) III-13

2. Europe III-14
A.Market Analysis III-14
Competitive landscape III-14
Next-generation VADs in Europe by Company (2007) III-14
Table 16: Heart Transplants and Patients Waiting List in
Europe (2005-2007): Figures in Units (includes
corresponding Graph/Chart) III-14
Belgium III-15
Reimbursement Scenario III-15
Key Data III-15
Table 17: Belgium VAD Market (2002-2005): Implants in
Units (includes corresponding Graph/Chart) III-15

Table 18: Belgium VAD Market (2002-2005): BTT Implants in
Units (includes corresponding Graph/Chart) III-15

Table 19: Belgium VAD Market (2004-2005): BTT Implants in
Units by Device - Incor, Excor, Novacor, Thoratec, Medos,and TCI HM (includes
corresponding Graph/Chart) III-16
Germany III-16
The United Kingdom III-16
Product Approvals/Innovations/Introductions III-17
Strategic Corporate Development III-18
Key Players III-18
B.Market Analytics III-19
Table 20: European Recent Past, Current & Future Analysis
for Ventricular Assist Devices Market Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2015 (includes corresponding Graph/Chart) III-19

Table 21: European Historic Review for Ventricular Assist
Devices Market Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2001 through 2005 (includes
corresponding Graph/Chart) III-20

3. Rest of World III-21
A.Market Analysis III-21
Product Innovations/Approvals III-21
Strategic Corporate Development III-21
Key Players III-21
B.Market Analytics III-22
Table 22: Rest of World Recent Past, Current & Future
Analysis for Ventricular Assist Devices Market Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2015 (includes corresponding Graph/Chart) III-22

Table 23: Rest of World Historic Review for Ventricular
Assist Devices Market Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2001 through 2005
(includes corresponding Graph/Chart) III-23

V. COMPETITIVE LANDSCAPE

To order this report:

World Ventricular Assist Devices Market

www.reportlinker.com/p0109889/World-Ventricular-Assist-Devices-Market.html?utm_s
urce=MRKW&utm_medium=PR&utm_campaign=MRKW

More market research reports here!

Contacts:
Reportlinker.com
Nicolas
US: (805) 652-2626 or Intl: +1-805-652-2626
nbo@reportlinker.com

Copyright 2009, Market Wire, All rights reserved.

-0-